Gabriel Levin, Clinical Fellow at McGill University Health Centre and Director of Oncology at CureLab Oncology, shared a post on LinkedIn:
“An important addition to our understanding of this aggressive and challenging histology – uterine leiomyosarcoma. Published in the International Journal of Gynecological Cancer (IJGC).
On multi-variable analysis, surgical approach was not independently associated with overall survival (aHR 1.16, 95% CI 0.91-1.49)
Survival was driven by age, stage, and margin status, not the surgical route.
Take-home:
In early-stage uterine leiomyosarcoma, the oncologic outcome appears driven by biology rather than approach. The critical unanswered question is not laparoscopy vs laparotomy – but how tumors are handled and extracted, and whether disruption plays a role.
Proud of this work, and of continuing to challenge assumptions in rare, high-risk disease.”
Title: Association of surgical approach with survival in clinically stage I uterine leiomyosarcoma: an National Cancer Database analysis
Authors: Gabriel Levin, Lucy Gilbert, Reitan Ribeiro, Rene Pareja, Shuk On Annie Leung, Xing Zeng, Raanan Meyer, Pedro T Ramirez
Other articles featuring Gabriel Levin on OncoDaily.